series-b
Stage
1
Investors
About
Liminal Biosciences is a development-stage biopharmaceutical company focused on creating novel small molecule therapeutics targeting G-protein coupled receptor pathways to treat metabolic, inflammatory, and fibrotic diseases.
Explore Liminal Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.